Education
About Us
Working with TipRanks
Follow Us
Doximity (DOCS)
NYSE:DOCS
DOCS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$25.00 - $85.21
Previous CloseN/A
Volume296.07K
Average Volume (3M)2.87M
Market Cap
$11.30B
Enterprise Value$10.82B
Total Cash (Recent Filing)$915.66M
Total Debt (Recent Filing)$12.40M
Price to Earnings (P/E)54.5
Beta1.39
Next Earnings
Aug 12, 2025EPS Estimate
0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.38
Shares Outstanding136,906,540
10 Day Avg. Volume1,854,746
30 Day Avg. Volume2,868,692
Financial Highlights & Ratios
PEG Ratio4.86
Price to Book (P/B)10.20
Price to Sales (P/S)0.00
P/FCF Ratio41.06
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue5.08
Enterprise Value/Gross Profit21.02
Enterprise Value/Ebitda12.22
Forecast
1Y Price Target
$61.27Price Target Upside1.42% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
Doximity News
Bulls Say, Bears Say
Bulls Say
AI InvestmentThere is optimism around Doximity's opportunity to leverage AI across its platform.
Financial StabilityDOCS has approximately $900M of cash, no debt, and high gross and EBITDA margins, which are favorable financial indicators.
Revenue GrowthDOCS' TTM net revenue retention rate of ~119% seems high, indicating strong customer retention and potential for revenue growth.
Bears Say
DTC Advertising ChallengesThe Trump administration is considering enacting changes that would make it more difficult and less cost-effective for pharma companies to conduct DTC advertising, which could benefit DOCS.
Macro DynamicsA Neutral rating is maintained due to caution on macro dynamics, despite improving business fundamentals.
Pharma Advertising LegislationThe introduction of the bill is inherently an incremental addition to the likelihood of a DTC pharma ad ban.
Ownership Overview
2.50% Insiders
32.04% Mutual Funds
27.31% Other Institutional Investors
18.86% Public Companies and Individual Investors
DOCS FAQ
What was Doximity’s price range in the past 12 months?
Doximity lowest stock price was $25.00 and its highest was $85.21 in the past 12 months.
What is Doximity’s market cap?
Doximity’s market cap is $11.30B.
When is Doximity’s upcoming earnings report date?
Doximity’s upcoming earnings report date is Aug 12, 2025 which is in 45 days.
How were Doximity’s earnings last quarter?
Doximity released its earnings results on May 15, 2025. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.272 by $0.108.
Is Doximity overvalued?
According to Wall Street analysts Doximity’s price is currently Undervalued.
Does Doximity pay dividends?
Doximity does not currently pay dividends.
What is Doximity’s EPS estimate?
Doximity’s EPS estimate is 0.3.
How many shares outstanding does Doximity have?
Doximity has 136,906,540 shares outstanding.
What happened to Doximity’s price movement after its last earnings report?
Doximity reported an EPS of $0.38 in its last earnings report, beating expectations of $0.272. Following the earnings report the stock price went down -10.077%.
Which hedge fund is a major shareholder of Doximity?
Currently, no hedge funds are holding shares in DOCS
Doximity Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$61.27 (1.42% Upside)
$61.27 (1.42% Upside)
Blogger Sentiment
Bullish
DOCS Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 64.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.3%
Last 30 Days ▲ 3.8%
Last 30 Days ▲ 3.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
118.32%
12-Months-Change
Fundamentals
Return on Equity
22.50%
Trailing 12-Months
Asset Growth
17.06%
Trailing 12-Months
Company Description
Doximity
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
DOCS Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Doximity demonstrated strong financial performance and user engagement, driven by revenue growth, robust EBITDA margins, and successful adoption of AI tools. Despite the strong results, the company remains cautious about potential macroeconomic challenges and tougher year-over-year comparisons.Read More>DOCS Revenue Breakdown
93.00% Subscription
7.00% Other
DOCS Stock 12 Month Forecast
Average Price Target
$61.27
▲(1.42%Upside)